Targeting lipid metabolism in multiple myeloma cells: Rational development of a synergistic strategy with proteasome inhibitors.
Xu G, Huang S, Peng J, Gao X, Li M, Yu S, Liu Z, Qie P, Wang Y, Yu S, Liu S, Wen H, Su L, Li P, Guang B, Dong R, Liu J, Yang T.
Xu G, et al. Among authors: li m, li p.
Br J Pharmacol. 2021 Dec;178(23):4741-4757. doi: 10.1111/bph.15653. Epub 2021 Sep 9.
Br J Pharmacol. 2021.
PMID: 34378191
Free article.